Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
โ Scribed by N. Ramnath; D. Tan; Q. Li; B. L. Hylander; P. Bogner; L. Ryes; S. Ferrone
- Book ID
- 105966964
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 437 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell
Changing the major histocompatibility complex (MHC) class I phenotype is a pivotal strategy of tumor cells to circumvent an effective immune response and is associated with tumor progression in cancer patients. Epithelial cells in bone marrow have been detected in various tumor types, but the clinic
To determine the possible functional significance of CD40 expression on human non-small cell lung carcinomas and to assess the potential of CD40 as a therapeutic target, 18 lung tumor cell lines were established from biopsy tissues and were monitored for phenotypic changes on the cell surface and al